Canopy Growth Corporation (TSX:WEED)
Canada · Delayed Price · Currency is CAD | Market Cap | 637.28M |
| Revenue (ttm) | 278.61M |
| Net Income (ttm) | -385.85M |
| Shares Out | 368.37M |
| EPS (ttm) | -2.12 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,873,577 |
| Average Volume | 8,924,686 |
| Open | 1.730 |
| Previous Close | 1.710 |
| Day's Range | 1.690 - 1.740 |
| 52-Week Range | 1.085 - 4.150 |
| Beta | 2.15 |
| RSI | 48.32 |
| Earnings Date | Feb 6, 2026 |
About Canopy Growth
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7A... [Read more]
Full Company ProfileFinancial Performance
In 2024, Canopy Growth's revenue was 269.00 million, a decrease of -9.47% compared to the previous year's 297.15 million. Losses were -598.12 million, -9.00% less than in 2023.
Financial StatementsNews
Canopy Growth Is Making Big Moves In Its Cannabis Business
Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts
In the latest trading session, Canopy Growth Corporation (CGC) closed at $1.23, marking a -4.65% move from the previous day.
Marijuana industry taking fight against Wall Street blockades straight to Trump
Bankers have argued that Pot Inc.'s far-bigger prospective business – recreational use that would include the smoking of joints and ingesting high-inducing gummies – wasn't specifically addressed by t...
Canopy Growth (CGC) Announces Strategic Moves to Strengthen Finances
Canopy Growth (CGC) Announces Strategic Moves to Strengthen Finances
Canopy Growth gains after recapitalization initiatives
Canopy Growth (CGC) stock rises as the Canadian cannabis player announces several recapitalization initiatives to boost its liquidity. Read more here.
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Canopy Growth Announces Strategic Recapitalization Transactions Significantly Strengthening Balance Sheet to Support Growth Strategy
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of ca...
Do These 2 Cannabis Stocks Have a Future?
Recent regulatory developments have improved the landscape of the cannabis industry in the U.S. Canopy Growth and Aurora Cannabis are two leaders in the Canadian market that could turn their attention...
I Was Right: President Trump Will Legalize Marijuana in 2026
President Trump has ordered that marijuana be reclassified as a Schedule III drug. The move doesn't fully legalize marijuana -- yet -- but it may foreshadow changes to come.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know
In the most recent trading session, Canopy Growth Corporation (CGC) closed at $1.32, indicating a -10.81% shift from the previous trading day.
Borrow Rate Surge for Canopy Growth (CGC)
Borrow Rate Surge for Canopy Growth (CGC)
Inside the dealmaking that pushed Trump to reclassify pot, expand access
President Donald Trump's marijuana reclassification executive order followed a yearlong push by cannabis executives, billionaire allies and political operatives combining donations, lobbying and targe...
After Trump's move to reclassify cannabis, here's what Wall Street is thinking
Analysts are now focused on the when the change will actually happen, as the cannabis industry waits for tax relief and expanded research opportunities.
Trump signs executive order to reschedule cannabis. Here's what's next
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted t...
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal gov...
Trump sparks market shock with MAJOR marijuana move
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's...
Former WH drug policy advisor: Mass commercialization and promotion of marijuana isn't a good thing
Kevin Sabet, Smart Approaches to Marijuana CEO, former White House drug policy advisor and ‘One Nation Under Influence' author, joins 'Squawk Box' to discuss President Trump's executive order to recla...
Down 99% in 5 Years, Is It Finally Time to Buy This Stock?
Canopy Growth's latest quarter was decent, with the company making progress on the bottom line. Some investors are hoping that positive regulatory developments in the U.S. could be a turning point.
Why US banks are still wary of cannabis despite Trump's policy shift
President Donald Trump's move to relax federal marijuana regulations has been welcomed by the US cannabis industry, but it has not changed the sector's most persistent challenge. Access to mainstream ...
How Trump's marijuana reclassification could impact medical research
Scotts Miracle-Gro CEO James Hagedorn discusses President Donald Trump signing an executive order to reclassify marijuana on ‘The Claman Countdown.' #fox #media #breakingnews #us #usa #new #news #brea...
Cannabis companies face hurdles accessing big banks despite reclassification, experts say
U.S. President Donald Trump's move to relax marijuana regulations could ease some burden for cannabis companies, but will likely keep doors to access capital from big banks closed, experts said.
Trulieve CEO Kim Rivers reacts to marijuana being reclassified
Trulieve Founder, Chair, and CEO Kim Rivers joins 'Fast Money' with reaction to Pres. Trump reclassifying marijuana.
Trump signed an executive order to reclassify marijuana.
About Yahoo Finance: Yahoo Finance provides free stock ticker data, up-to-date news, portfolio management resources, comprehensive market data, advanced tools, and more information to help you manage ...
Trump signs order to expedite marijuana reschedules, Kevin Hassett vs. Kevin Warsh in Fed chair race
Market Domination Overtime anchor Josh Lipton breaks down the latest market moves for December 18, 2025. President Trump signed an executive order today to expedite the rescheduling of marijuana.